Raymond James & Associates’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-362
Closed -$26K 4298
2021
Q3
$26K Hold
362
﹤0.01% 3981
2021
Q2
$30K Buy
362
+28
+8% +$2.12K ﹤0.01% 3953
2021
Q1
$23K Buy
334
+28
+9% +$2.19K ﹤0.01% 3912
2020
Q4
$20K Sell
306
-473
-61% -$22.6K ﹤0.01% 3687
2020
Q3
$33K Sell
779
-175
-18% -$7.72K ﹤0.01% 3479
2020
Q2
$43K Hold
954
﹤0.01% 3394
2020
Q1
$45K Sell
954
-29
-3% -$1.37K ﹤0.01% 3328
2019
Q4
$41K Sell
983
-143
-13% -$6.18K ﹤0.01% 3568
2019
Q3
$53K Sell
1,126
-428
-28% -$18.9K ﹤0.01% 3462
2019
Q2
$71K Hold
1,554
﹤0.01% 3456
2019
Q1
$83K Hold
1,554
﹤0.01% 3427
2018
Q4
$53K Sell
1,554
-936
-38% -$41.2K ﹤0.01% 3381
2018
Q3
$142K Buy
2,490
+143
+6% +$9.05K ﹤0.01% 3380
2018
Q2
$181K Hold
2,347
﹤0.01% 3290
2018
Q1
$189K Buy
2,347
+762
+48% +$154K ﹤0.01% 3150
2017
Q4
$394K Buy
1,585
+661
+72% +$154K ﹤0.01% 2678
2017
Q3
$197K Sell
924
-229
-20% -$39.2K ﹤0.01% 3052
2017
Q2
$180K Buy
1,153
+729
+172% +$138K ﹤0.01% 3013
2017
Q1
$82K Buy
+424
New +$81.4K ﹤0.01% 3098
2016
Q4
Sell
-362
Closed -$66K 3372
2016
Q3
$66K Buy
+362
New +$54.3K ﹤0.01% 3059

Other funds holding NTBL

Raymond James & Associates's NTBL Position: Q4 2021 in Review

Raymond James & Associates sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q4 2021, closing a stake of 362 shares — an estimated $26K sold.

Raymond James & Associates first reported a position in NTBL in Q3 2016 and held it in 20 quarters. The position peaked at $394K in Q4 2017. 26 funds tracked by Wall St. Rank hold NTBL as of Q4 2021.

  • Raymond James & Associates reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Raymond James & Associates sold 362 Notable Labs, Ltd. Ordinary Shares shares in Q4 2021, an estimated $26K.
  • Raymond James & Associates first reported a position in Notable Labs, Ltd. Ordinary Shares in Q3 2016 and held it in 20 quarters.
  • Raymond James & Associates's Notable Labs, Ltd. Ordinary Shares position peaked at $394K in Q4 2017.
  • 26 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q4 2021.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.